Dr Reddys Laboratories Ltd
NSE :DRREDDY BSE :500124 Sector : PharmaceuticalsBuy, Sell or Hold DRREDDY? Ask The Analyst
BSE
prev close
OPEN PRICE
volume
Today's low / high
52 WK low / high
bid price (qty)
offer price (qty)
NSE
prev close
open price
volume
Today's' low / high
52 WK low / high
bid price (qty)
offer price (qty)
10 Jan 1354.40 (-1.25%) | 09 Jan 1371.60 (0.06%) | 08 Jan 1370.75 (1.42%) | 07 Jan 1351.55 (0.09%) | 06 Jan 1350.35 (-0.17%) | 03 Jan 1352.65 (-1.63%) | 02 Jan 1375.05 (0.44%) | 01 Jan 1369.00 (-1.40%) | 31 Dec 1388.50 (0.84%) | 30 Dec 1376.90 (-0.90%) | 27 Dec 1389.45 (2.53%) | 26 Dec 1355.15 (0.31%) | 24 Dec 1350.90 (0.71%) | 23 Dec 1341.35 (-0.17%) | 20 Dec 1343.65 (1.36%) | 19 Dec 1325.60 (3.94%) | 18 Dec 1275.40 (2.22%) | 17 Dec 1247.65 (-1.76%) | 16 Dec 1269.95 (1.89%) | 13 Dec 1246.35 (0.08%) | 12 Dec 1245.40 (0.55%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bullish
Medium Term Investors
Very Bullish
Long Term Investors
Neutral
Moving Averages
5 DMA
Bearish
1359.56
10 DMA
Bearish
1365.96
20 DMA
Bullish
1340.19
50 DMA
Bullish
1279.73
100 DMA
Bullish
1311.45
200 DMA
Bullish
1283.49
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Jan 10, 2025 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1409.46 | 1397.73 | 1363.59 | - | - |
R2 | 1397.73 | 1384.97 | 1360.52 | 1395.25 | - |
R1 | 1376.06 | 1377.09 | 1357.46 | 1371.1 | 1386.9 |
P | 1364.33 | 1364.33 | 1364.33 | 1361.85 | 1369.75 |
S1 | 1342.66 | 1351.57 | 1351.34 | 1337.7 | 1353.5 |
S2 | 1330.93 | 1343.69 | 1348.28 | 1328.45 | - |
S3 | 1309.26 | 1330.93 | 1345.22 | - | - |
Key Metrics
EPS
57.64
P/E
23.49
P/B
4.2
Dividend Yield
0.59%
Market Cap
1,13,014 Cr.
Face Value
1
Book Value
322.47
ROE
21.64%
EBITDA Growth
2,389.1 Cr.
Debt/Equity
0.06
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Dr Reddys Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 7221.8 | 7455.7 | 7314.8 | 7889.2 | 8351.8 | |
PROFIT | 1482.2 | 1380.9 | 1309.8 | 1392.4 | 1255.7 | |
EPS | 89.09 | 82.94 | 78.66 | 83.61 | 75.4 |
Dr Reddys Laboratories Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | ||
INCOME | 5061.8 | 4330.6 | 5317.5 | 6059 | 6903.9 | |
PROFIT | 1192.6 | 475.2 | 1034.8 | 1417.2 | 1882.1 | |
EPS | 71.68 | 28.55 | 62.14 | 85.1 | 113 |
Profit & Loss (Figures in Rs. Crores)
Dr Reddys Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 15353.2 | 15959 | 14490.9 | 14477.7 | 16104.9 | 18170 | 20177.4 | 22453.8 | 25691.3 | 29600.6 | |
PROFIT | 2291.79 | 2071.62 | 1252.3 | 892.34 | 1849.63 | 2030.35 | 1954.44 | 2110.85 | 4597.54 | 5512.22 | |
EPS | 26.61 | 24.71 | 15.17 | 10.99 | 23.49 | 24.38 | 23.46 | 26.23 | 54.11 | 66.88 |
Dr Reddys Laboratories Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 10262.7 | 10645.6 | 10309.1 | 9614.9 | 10797.9 | 12693.5 | 14545.8 | 15276.8 | 17424.3 | 20584.9 | |
PROFIT | 1634.01 | 1320.26 | 1406.23 | 536.19 | 1274.22 | 2948.85 | 1849.38 | 1628.89 | 2628.55 | 4284.19 | |
EPS | 18.9 | 16.11 | 16.7 | 6.83 | 15.39 | 35.35 | 26.28 | 19.51 | 31.37 | 52.06 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 83.4 | 83.3 | 83.2 | 83.2 | 83.1 | 83 | 83 | 82.9 | 85.3 | 85.2 |
Reserves Total | 28,270.5 | 23,329.7 | 19,289.3 | 17,755.2 | 15,616.3 | 13,994.1 | 12,488.6 | 12,179.2 | 12,484.5 | 9,767.9 |
Equity Application Money | -99.1 | -126.9 | -160.1 | -196.7 | -100.6 | -53.5 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 28,254.8 | 23,286.1 | 19,212.4 | 17,641.7 | 15,598.8 | 14,023.6 | 12,571.6 | 12,262.1 | 12,569.8 | 9,853.1 |
Secured Loans | 0 | 0 | 0 | 0 | 178.7 | 60.9 | 69.3 | 70.7 | 85.7 | 86.2 |
Unsecured Loans | 2,002 | 1,347.2 | 3,384.5 | 3,030.8 | 2,031.5 | 3,777.2 | 5,002.1 | 4,847.8 | 3,266.4 | 4,227.9 |
Total Debt | 2,002 | 1,347.2 | 3,384.5 | 3,030.8 | 2,210.2 | 3,838.1 | 5,071.4 | 4,918.5 | 3,352.1 | 4,314.1 |
Other Liabilities | 337.9 | 223.1 | 192.7 | 212.5 | 280 | 297.4 | 375 | 427.6 | 344.5 | 351.2 |
Total Liabilities | 30,594.7 | 24,856.4 | 22,789.6 | 20,885 | 18,089 | 18,159.1 | 18,018 | 17,608.2 | 16,266.4 | 14,518.4 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 28,062.2 | 25,567.1 | 23,096.4 | 18,555.7 | 16,108.2 | 14,998.6 | 17,436.3 | 15,932.4 | 15,019.7 | 12,573.6 |
Less: Accumulated Depreciation | 17,636.6 | 16,348 | 14,974.9 | 10,350 | 9,257.9 | 7,807.6 | 10,468.3 | 9,001.7 | 8,456.7 | 7,196.6 |
Net Block | 10,425.6 | 9,219.1 | 8,121.5 | 8,205.7 | 6,850.3 | 7,191 | 6,968 | 6,930.7 | 6,563 | 5,377 |
Capital Work in Progress | 1,419.3 | 1,030.1 | 1,293.4 | 1,565.1 | 1,535.1 | 2,933.5 | 3,470.5 | 3,324.5 | 772.2 | 529 |
Investments | 4,930.5 | 4,985.8 | 2,615.9 | 2,211.8 | 2,677.8 | 2,587.1 | 2,298.3 | 2,109.7 | 3,833.1 | 2,247.8 |
Inventories | 6,355.2 | 4,867 | 5,088.4 | 4,541.2 | 3,506.7 | 3,357.9 | 2,908.9 | 2,852.8 | 2,557.9 | 2,569.9 |
Sundry Debtors | 8,029.8 | 7,248.5 | 6,676.4 | 4,964.1 | 5,027.8 | 3,986.9 | 4,052.7 | 3,798.6 | 4,125 | 4,101.2 |
Cash and Bank Balance | 1,727.7 | 1,730.2 | 2,419.2 | 2,078.8 | 205.3 | 222.8 | 263.8 | 386.5 | 492.1 | 1,872.4 |
Loans and Advances | 4,287.6 | 2,130.2 | 1,581 | 1,587.7 | 1,490.6 | 1,289.6 | 1,440 | 1,218.7 | 1,115.6 | 1,231 |
Total Current Assets | 20,400.3 | 15,975.9 | 15,765 | 13,171.8 | 10,230.4 | 8,857.2 | 8,665.4 | 8,256.6 | 8,290.6 | 9,774.5 |
Current Liabilities | 7,258.9 | 6,485.9 | 5,825.1 | 5,062.6 | 4,610.2 | 3,762.2 | 3,739.6 | 3,385.6 | 3,304.6 | 2,794.8 |
Provisions | 926.1 | 866.8 | 1,130.8 | 640.3 | 524.1 | 497 | 591.7 | 660.7 | 759.4 | 1,143.9 |
Total Current Liabilities & Provisions | 8,185 | 7,352.7 | 6,955.9 | 5,702.9 | 5,134.3 | 4,259.2 | 4,331.3 | 4,046.3 | 4,064 | 3,938.7 |
Net Current Assets | 12,215.3 | 8,623.2 | 8,809.1 | 7,468.9 | 5,096.1 | 4,598 | 4,334.1 | 4,210.3 | 4,226.6 | 5,835.8 |
Deferred Tax Assets | 1,057.8 | 705.2 | 1,277 | 1,068.6 | 1,219.9 | 431.7 | 540.5 | 678.4 | 590.5 | 260.5 |
Deferred Tax Liability | 84.1 | 76 | 1.4 | 28.9 | 2 | 47.3 | 195 | 162 | 53.7 | 156.2 |
Net Deferred Tax | 973.7 | 629.2 | 1,275.6 | 1,039.7 | 1,217.9 | 384.4 | 345.5 | 516.4 | 536.8 | 104.3 |
Other Assets | 630.3 | 369 | 674.1 | 393.8 | 711.8 | 465.1 | 601.6 | 516.6 | 334.7 | 424.5 |
Total Assets | 30,594.7 | 24,856.4 | 22,789.6 | 20,885 | 18,089 | 18,159.1 | 18,018 | 17,608.2 | 16,266.4 | 14,518.4 |
Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 138 | 277.57 | 102.17 | 92.17 | 190 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 83.4 | 83.3 | 83.2 | 83.2 | 83.1 | 83 | 83 | 82.9 | 85.3 | 85.2 |
Reserves Total | 24,256.5 | 20,517.8 | 18,413.1 | 17,097.2 | 15,209.4 | 12,654.6 | 11,724.8 | 11,517.7 | 11,993.1 | 10,548.8 |
Equity Application Money | -99.1 | -126.9 | -160.1 | -196.7 | -100.6 | -53.5 | 0 | 0 | 0 | 0 |
Total Shareholders Funds | 24,240.8 | 20,474.2 | 18,336.2 | 16,983.7 | 15,191.9 | 12,684.1 | 11,807.8 | 11,600.6 | 12,078.4 | 10,634 |
Secured Loans | 0 | 0 | 0 | 0 | 19.3 | 0 | 0 | 0 | 0.9 | 1.4 |
Unsecured Loans | 792.9 | 50.8 | 2,205.4 | 1,214.5 | 1,437.6 | 1,064.6 | 2,588.8 | 2,355.2 | 3,084.2 | 3,124.7 |
Total Debt | 792.9 | 50.8 | 2,205.4 | 1,214.5 | 1,456.9 | 1,064.6 | 2,588.8 | 2,355.2 | 3,085.1 | 3,126.1 |
Other Liabilities | 114.8 | 93.1 | 94.6 | 67.9 | 84.1 | 83.2 | 84.6 | 103.4 | 123.6 | 75.3 |
Total Liabilities | 25,148.5 | 20,618.1 | 20,636.2 | 18,266.1 | 16,732.9 | 13,831.9 | 14,481.2 | 14,059.2 | 15,287.1 | 13,835.4 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 16,297.2 | 15,136.6 | 13,349.1 | 12,345 | 10,215.9 | 9,774.1 | 9,223.6 | 8,675.4 | 7,580 | 5,815.6 |
Less : Accumulated Depreciation | 8,708.1 | 7,941.3 | 7,198.6 | 6,500.7 | 5,782 | 5,091.4 | 4,506.3 | 3,833.3 | 3,141.9 | 2,566.2 |
Net Block | 7,589.1 | 7,195.3 | 6,150.5 | 5,844.3 | 4,433.9 | 4,682.7 | 4,717.3 | 4,842.1 | 4,438.1 | 3,249.4 |
Capital Work in Progress | 1,211 | 924.4 | 1,200.3 | 900.8 | 411.8 | 400.1 | 675 | 540 | 616.1 | 488.3 |
Investments | 7,320.6 | 7,440 | 4,936.7 | 4,649.2 | 5,485.5 | 3,933.5 | 3,636.5 | 3,101.9 | 5,076.1 | 3,862.3 |
Inventories | 4,018.9 | 3,043 | 3,347.8 | 2,819.7 | 2,190.4 | 2,015.6 | 1,856.8 | 1,809.7 | 1,699.6 | 1,723.3 |
Sundry Debtors | 4,623.9 | 4,288.9 | 4,945.4 | 4,080 | 4,638.7 | 3,717.7 | 4,203.8 | 4,405.4 | 3,889.5 | 4,711.7 |
Cash and Bank Balance | 1,216.9 | 645.8 | 2,030.5 | 1,646.5 | 39.2 | 113.2 | 120.7 | 66.8 | 202.1 | 901.4 |
Loans and Advances | 3,838.3 | 1,512.8 | 1,255.2 | 1,141 | 1,120 | 972.3 | 1,174.4 | 1,012.8 | 1,121.9 | 964.7 |
Total Current Assets | 13,698 | 9,490.5 | 11,578.9 | 9,687.2 | 7,988.3 | 6,818.8 | 7,355.7 | 7,294.7 | 6,913.1 | 8,301.1 |
Current Liabilities | 4,399.4 | 4,112.3 | 3,537.2 | 3,064.8 | 2,535.6 | 2,175.4 | 2,445.7 | 2,179.6 | 2,127.5 | 1,952.1 |
Provisions | 395.3 | 305.2 | 322.2 | 298.7 | 207.3 | 184.7 | 173.4 | 208.4 | 170.6 | 539.5 |
Total Current Liabilities & Provisions | 4,794.7 | 4,417.5 | 3,859.4 | 3,363.5 | 2,742.9 | 2,360.1 | 2,619.1 | 2,388 | 2,298.1 | 2,491.6 |
Net Current Assets | 8,903.3 | 5,073 | 7,719.5 | 6,323.7 | 5,245.4 | 4,458.7 | 4,736.6 | 4,906.7 | 4,615 | 5,809.5 |
Deferred Tax Assets | 0 | 0 | 441.6 | 582.1 | 867.3 | 214.1 | 346.5 | 382.8 | 306 | 35.7 |
Deferred Tax Liability | 416.1 | 339.2 | 422.2 | 327.3 | 254.4 | 269.6 | 253.4 | 300.7 | 242.5 | 164.7 |
Net Deferred Tax | -416.1 | -339.2 | 19.4 | 254.8 | 612.9 | -55.5 | 93.1 | 82.1 | 63.5 | -129 |
Other Assets | 540.6 | 324.6 | 609.8 | 293.3 | 543.4 | 412.4 | 622.7 | 586.4 | 478.3 | 554.9 |
Total Assets | 25,148.5 | 20,618.1 | 20,636.2 | 18,266.1 | 16,732.9 | 13,831.9 | 14,481.2 | 14,059.2 | 15,287.1 | 13,835.4 |
Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 316.2 | 305.37 | 102.17 | 92.17 | 1,231.9 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 7,201 |
Depreciation | 1,470 |
Interest (Net) | -56.7 |
Dividend Received | 44.5 |
P/L on Sales of Assets | -90 |
Prov. and W/O (Net) | 384.1 |
P/L in Forex | -53.3 |
Total Adjustments (PBT and Ext... | 1,365.2 |
Operating Profit before Workin... | 8,566.2 |
Trade and 0ther Receivables | -805.4 |
Inventories | -1,844.5 |
Trade Payables | 346 |
Total Adjustments (OP before W... | -2,018.2 |
Cash Generated from/(used in) ... | 6,548 |
Direct Taxes Paid | -2,004.7 |
Total Adjustments(Cash Generat... | -2,004.7 |
Cash Flow before Extraordinary... | 4,543.3 |
Net Cash from Operating Activi... | 4,543.3 |
Purchased of Fixed Assets | -2,743.5 |
Sale of Fixed Assets | 108.5 |
Purchase of Investments | -14,550 |
Sale of Investments | 12,978.4 |
Interest Received | 133.8 |
Net Cash used in Investing Act... | -4,034.2 |
Proceeds from Issue of shares ... | 80.5 |
Proceed from 0ther Long Term B... | 380 |
Proceed from Short Tem Borrowi... | 549.3 |
Of the Long Tem Borrowings | -380 |
Of Financial Liabilities | -114.7 |
Dividend Paid | -664.8 |
Interest Paid | -226.6 |
Net Cash used in Financing Act... | -376.3 |
Net Profit before Tax and Extr... | 5,791.3 |
Depreciation | 975.6 |
Interest (Net) | -282.8 |
Dividend Received | 44.6 |
Prov. and W/O (Net) | 284.8 |
P/L in Forex | 7.6 |
Total Adjustments (PBT and Ext... | 602 |
Operating Profit before Workin... | 6,393.3 |
Trade and 0ther Receivables | -348.1 |
Inventories | -1,217 |
Trade Payables | 280.3 |
Total Adjustments (OP before W... | -1,624.1 |
Cash Generated from/(used in) ... | 4,769.2 |
Direct Taxes Paid | -1,319.5 |
Total Adjustments(Cash Generat... | -1,319.5 |
Cash Flow before Extraordinary... | 3,449.7 |
Net Cash from Operating Activi... | 3,449.7 |
Purchased of Fixed Assets | -1,593.6 |
Sale of Fixed Assets | 88.2 |
Purchase of Investments | -13,757.8 |
Sale of Investments | 11,746.8 |
Interest Received | 182.3 |
Loans to Subsidiaires | -60.6 |
Acquisition of Companies | -80.2 |
Net Cash used in Investing Act... | -3,428.7 |
Proceeds from Issue of shares ... | 80.5 |
Proceed from Short Tem Borrowi... | 709.4 |
Of Financial Liabilities | -23.7 |
Dividend Paid | -664.8 |
Interest Paid | -33.3 |
Net Cash used in Financing Act... | 68.1 |
Company Details
Registered Office |
|
Address | 8-2-337 Road No 3, Banjara Hills |
City | Hyderabad |
State | Telangana |
Pin Code | 500034 |
Tel. No. | 91-40-49002900 |
Fax. No. | 91-40-49002999 |
shares@drreddys.com; mail@drreddys.com | |
Internet | http://www.drreddys.com |
Registrars |
|
Address | 8-2-337 Road No 3 |
City | Hyderabad |
State | Telangana |
Pin Code | 500034 |
Tel. No. | 91-40-49002900 |
Fax. No. | 91-40-49002999 |
shares@drreddys.com; mail@drreddys.com | |
Internet | http://www.drreddys.com |
Management |
|
Name | Designation |
G V Prasad | Co-Chairman & Managing Directo |
K Satish Reddy | Executive Chairman |
Shikha Sanjaya Sharma | Independent Director |
Leo Puri | Lead Independent Director |
K P Krishnan | Independent Director |
Pennv Wan | Independent Director |
K Randhir Singh | Company Sec. & Compli. Officer |
Arun M. Kumar | Independent Director |
Claudio Albrecht | Independent Director |
Sanjiv Mehta | Independent Director |
Alpna Seth | Independent Director |